Darvish Nissim 4
4 · 9 METERS BIOPHARMA, INC. · Filed Jul 8, 2020
Insider Transaction Report
Form 4
Darvish Nissim
Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2020-07-06+100,000→ 100,000 total(indirect: see footnote)Exercise: $0.62Exp: 2030-07-06→ Common stock (100,000 underlying)
Footnotes (2)
- [F1]The option shall vest in 36 equal monthly installments beginning July 6, 2020.
- [F2]The Reporting Person is the designated representative of OrbiMed Israel GP Ltd. on the Issuer's Board of Directors. The reportable securities are owned indirectly by OrbiMed Israel Partners Limited Partnership ("OIP"). OrbiMed Israel BioFund GP Limited Partnership ("OrbiMed BioFund") is the general partner of OIP, and OrbiMed Israel GP Ltd. ("OrbiMed Israel") is the general partner of OrbiMed BioFund. The Reporting Person disclaims beneficial ownership of the securities reported herein for the purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any.